| 46.58 Delayed Data As of Aug 23 |  -1.28 / -2.67%Today’s Change | 42.48 Today|||52-Week Range 63.69 | -10.39% Year-to-Date |
| Previous close | 47.86 |
| Today’s open | 47.77 |
| Day’s range | 46.29 - 48.20 |
| Volume | 16,321,221 |
| Average volume (3 months) | 13,628,714 |
| Market cap | $76.2B |
| Earnings growth (last year) | +393.92% |
| Earnings growth (this year) | +6.65% |
| Earnings growth (next 5 years) | +5.01% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 12.3 |
| Price/Sales | 3.77 |
| Price/Book | 5.39 |
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene | -1.72 | -1.80% |
| ZTSZoetis Inc | -3.57 | -2.82% |
| NVONovo Nordisk | -0.43 | -0.82% |
| ABBVAbbVie | -1.55 | -2.30% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | $1.06 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
